Central nervous system infections in individuals with HIV-1 infection

被引:0
|
作者
Arunima Mamidi
Joseph A. DeSimone
Roger J. Pomerantz
机构
[1] Thomas Jefferson University,Division of Infectious Diseases, Department of Medicine, Jefferson Medical College
来源
关键词
human immunodeficiency virus type 1; toxoplasma encephalitis; cryptococcal meningitis; cytomegalovirus encephalitis; progressive multifocal leukoencephalopathy;
D O I
暂无
中图分类号
学科分类号
摘要
Opportunistic infections of the central nervous system (CNS) are common complications of advanced immunodeficiency in individuals with human immunodeficiency virus type 1 (HIV-1) infection. Neurological disease is the first manifestation of acquired immunodeficiency syndrome (AIDS) in 10% to 20% of symptomatic HIV-1 infection. Prompt diagnosis and treatment of such disorders is critical. Also, in the era of highly active antiretroviral therapy (HAART), these disease states have changed in presentation and epidemiology. Therefore, we review the epidemiology, pathogenesis, clinical features, diagnosis, and management of five common central nervous system disorders in individuals with HIV-1 infection: toxoplasma encephalitis, primary central nervous system lymphoma, cryptococcal meningitis, cytomegalovirus encephalitis, and progressive multifocal leukoencephalopathy.
引用
收藏
页码:158 / 167
页数:9
相关论文
共 50 条
  • [41] Novel approaches utilizing human brain tissue to investigate HIV-1 infection of the central nervous system
    Van Duyne, Rachel
    Irollo, Elena
    O'Brien, Erick
    Johnson, James
    Jackson, Joshua
    Sarkar, Atom
    Klase, Zachary
    Meucci, Olimpia
    [J]. JOURNAL OF NEUROVIROLOGY, 2023, 29 : S33 - S33
  • [42] Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection
    Lars Hagberg
    Paola Cinque
    Magnus Gisslen
    Bruce J Brew
    Serena Spudich
    Arabella Bestetti
    Richard W Price
    Dietmar Fuchs
    [J]. AIDS Research and Therapy, 7
  • [43] Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection
    Hagberg, Lars
    Cinque, Paola
    Gisslen, Magnus
    Brew, Bruce J.
    Spudich, Serena
    Bestetti, Arabella
    Price, Richard W.
    Fuchs, Dietmar
    [J]. AIDS RESEARCH AND THERAPY, 2010, 7
  • [44] Emergence of raltegravir-resistant HIV-1 in the central nervous system
    Watanabe, K.
    Honda, M.
    Watanabe, T.
    Tsukada, K.
    Teruya, K.
    Kikuchi, Y.
    Oka, S.
    Gatanaga, H.
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2010, 21 (12) : 840 - 841
  • [45] Compartmentalization of HIV-1 in the central nervous system: role of the choroid plexus
    Burkala, EJ
    He, J
    West, JT
    Wood, C
    Petito, CK
    [J]. AIDS, 2005, 19 (07) : 675 - 684
  • [46] Neuropathogenesis of Central Nervous System HIV Infection
    McGuire, Jennifer L.
    Goodkin, Karl
    Douglas, Steven D.
    [J]. PSYCHIATRIC ANNALS, 2013, 43 (05) : 212 - 216
  • [47] Treating HIV Infection in the Central Nervous System
    A. Calcagno
    G. Di Perri
    S. Bonora
    [J]. Drugs, 2017, 77 : 145 - 157
  • [48] HIV Infection and the Central Nervous System: A Primer
    Ronald J. Ellis
    Patricia Calero
    Michael D. Stockin
    [J]. Neuropsychology Review, 2009, 19 : 144 - 151
  • [49] Treating HIV Infection in the Central Nervous System
    Calcagno, A.
    Di Perri, G.
    Bonora, S.
    [J]. DRUGS, 2017, 77 (02) : 145 - 157
  • [50] HIV Infection and the Central Nervous System: A Primer
    Ellis, Ronald J.
    Calero, Patricia
    Stockin, Michael D.
    [J]. NEUROPSYCHOLOGY REVIEW, 2009, 19 (02) : 144 - 151